Renovorx announces first patient enrolled at university of nebraska medical center for the ongoing pivotal phase iii tiger-pac clinical trial

Phase iii clinical trial is evaluating renovogem™ for the treatment of locally advanced pancreatic cancer unmc opened enrollment of tiger-pac in june 2024 and joins esteemed clinical sites throughout united states participating in the study los altos, calif., aug. 14, 2024 (globe newswire) -- renovorx, inc.
RNXT Ratings Summary
RNXT Quant Ranking